AtriCure PE ratio ATRC

Share price divided by earnings per share over the last twelve months, since 2021.

Today, Oct 23, 2026: 281×
5-year median: 58.4×
Against its 5-year history: 99th; percentile: 0 is its lowest day, 100 its highest
5-year range: 28.9× to 281×
Peer median: 36.9×

AtriCure's PE ratio is 281× as of Oct 23, 2026: a share price of $58.97 against $0.21 of earnings per share over the last twelve months.

That is above its 5-year median of 58.4×, higher than on 99% of days in the last 5 years.

Over that time it ranged from 28.9× in Oct 2022 to 281× in Oct 2026.

The median for 10 medical instruments and supplies stocks of a similar size is 36.9×.

PE ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	281×	180×	281×
2025	n/m a value too high to mean anything
2024	n/m a value too high to mean anything
2023	n/m a value too high to mean anything
2022	36.1×	28.9×	68.9×
2021	73.2×	68.6×	91.7×

Against its peers

Companies in Medical - Instruments & Supplies nearest AtriCure's size, closest first, today.

Company	PE ratio
ATRCAtriCure	281×
WRBYWarby Parker	370×
NVSTEnvista	40.7×
UFPTUFP Technologies	31.9×
ICUIICU Medical	141×
INSPInspire Medical Systems	15.4×
BMIBadger Meter	35.3×
VNTVontier	14.3×
LMATLemaitre Vascular	29.6×
HAEHaemonetics	58.1×
MMSIMerit Medical Systems	38.6×
Peer median	36.9×

Where AtriCure ranks

#35of 35Medical instruments and supplies stocks with the lowest PE ratio

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on AtriCure

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.